32 phenotypes from 3 alleles in 2 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Mfsd1em1(IMPC)Tcp/Mfsd1+ C57BL/6N-Mfsd1em1(IMPC)Tcp/Tcp	anophthalmia	J:211773
	enlarged lymph nodes	J:211773
Mfsd1em1(IMPC)Tcp/Mfsd1em1(IMPC)Tcp C57BL/6N-Mfsd1em1(IMPC)Tcp/Tcp	abnormal eye morphology	J:211773
	abnormal liver morphology	J:211773
	abnormal retina blood vessel morphology	J:211773
	abnormal retina vasculature morphology	J:211773
	abnormal sternum morphology	J:211773
	decreased circulating triglyceride level	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased mean platelet volume	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
	persistence of hyaloid vascular system	J:211773
	preweaning lethality, incomplete penetrance	J:211773
	small testis	J:211773
	thrombocytopenia	J:211773
Mfsd1tm1a(KOMP)Wtsi/Mfsd1tm1a(KOMP)Wtsi involves: C57BL/6N	abnormal hepatocyte morphology	J:280713
	abnormal liver morphology	J:280713
	abnormal liver parenchyma morphology	J:280713
	abnormal liver perisinusoidal space morphology	J:280713
	abnormal liver sinusoid morphology	J:280713
	abnormal liver sinusoidal endothelial cell morphology	J:280713
	abnormal liver vasculature morphology	J:280713
	decreased body weight	J:280713
	enlarged spleen	J:280713
	increased circulating alanine transaminase level	J:280713
	increased circulating aspartate transaminase level	J:280713
	increased circulating glutamate dehydrogenase level	J:280713
	increased liver tumor incidence	J:280713
	liver fibrosis	J:280713
Mfsd1tm1d(KOMP)Wtsi/Mfsd1tm1d(KOMP)Wtsi involves: C57BL/6N	abnormal liver morphology	J:280713